Altered expression of S100 fused-type proteins in an atopic dermatitis skin model

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder with elevated interleukin (IL)-4 and IL-13 signatures and extensive barrier dysfunction, which is correlated with the downregulation of filaggrin (FLG). FLG is a member of the S100 fused-type protein family and this family also includes cornulin (CRNN), filaggrin-2 (FLG2), hornerin (HRNR) repetin (RPTN), trichohyalin (TCHH) and trichohyalin-like 1 (TCHHL1). The present study aimed to examine the effects of IL-4 and IL-13 and the downregulation of FLG on the expression of S100 fused-type proteins using a three-dimensional (3D) AD skin model by immunohistochemical study and quantitative polymerase chain reaction. In the 3D AD skin model, which was generated by a stimulation of recombinant IL-4 and IL-13, the expression of FLG, FLG2, HRNR and TCHH was decreased, while that of RPTN was increased in comparison to the 3D control skin. In the FLG knockdown (KD) 3D skin model, which was generated using FLG siRNA, the expression of HRNR was increased. The expression of the other proteins did not differ to a statistically significant extent. The expression of fused-S100 type protein family members may differ in AD skin. This suggests that these proteins play different roles in the pathogenesis of AD.

Original languageEnglish
Pages (from-to)2160-2165
Number of pages6
JournalExperimental Dermatology
Volume32
Issue number12
DOIs
StatePublished - 2023/12

Keywords

  • S100 fused-type proteins
  • atopic dermatitis
  • filaggrin
  • three-dimensional skin equivalent
  • type 2 cytokines

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology

Fingerprint

Dive into the research topics of 'Altered expression of S100 fused-type proteins in an atopic dermatitis skin model'. Together they form a unique fingerprint.

Cite this